{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:08:22Z","timestamp":1793513302304,"version":"4.5.0"},"reference-count":110,"publisher":"Informa UK Limited","issue":"11","funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AR079588"],"award-info":[{"award-number":["K23AR079588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/1744666x.2023.2249237","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T01:16:27Z","timestamp":1692407787000},"page":"1385-1397","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":40,"title":["JAK inhibitors and black box warnings: what is the future for JAK inhibitors?"],"prefix":"10.1080","volume":"19","author":[{"given":"Kate","family":"Tokareva","sequence":"first","affiliation":[{"name":"Medical Student, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-0919","authenticated-orcid":false,"given":"Pankti","family":"Reid","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Committee on Clinical Pharmacology and Pharmacogenomics, Department of Medicine, University of Chicago Biological Sciences Division, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-9865","authenticated-orcid":false,"given":"Victor","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-8883","authenticated-orcid":false,"given":"David","family":"Liew","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Austin Health, Melbourne, Victoria, Australia"},{"name":"Department of Clinical Pharmacology and Therapeutics, Austin Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Seattle Epidemiologic Research and Information Center (ERIC), VA Puget Sound Healthcare System, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Baraff","sequence":"additional","affiliation":[{"name":"Seattle Epidemiologic Research and Information Center (ERIC), VA Puget Sound Healthcare System, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Giles","sequence":"additional","affiliation":[{"name":"Columbia University, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7149-363X","authenticated-orcid":false,"given":"Namrata","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00438-4"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41906"},{"issue":"2","key":"e_1_3_4_5_1","first-page":"318","article-title":"The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge JA","year":"2016","unstructured":"Hodge JA, Kawabata TT, Krishnaswami S, et al. The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(2):318\u2013328.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219012"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051001"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41580"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-8-5"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61424-X"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109071"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37816"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112072"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00006"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223715"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222259"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222543"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223050"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221915"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab570"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead163"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00799-z"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac059"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02445-w"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134527"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002735"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad100"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac141"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218510"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.001"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.01.039"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11479"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.3516"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.928471"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224049"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01333-0"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218398"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100096"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103276"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002236"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00266-6"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000910"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955035"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.051"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00701-3"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01873-w"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2023.2200166"},{"key":"e_1_3_4_50_1","first-page":"1","article-title":"Protein kinases: drug targets for immunological disorders","author":"Castelo-Soccio L","year":"2023","unstructured":"Castelo-Soccio L, Kim H, Gadina M, et al. Protein kinases: drug targets for immunological disorders. Nat Rev Immunol. 2023;1\u201320.","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00331-3"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00044-3"},{"key":"e_1_3_4_53_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04774224"},{"key":"e_1_3_4_54_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00044304"},{"key":"e_1_3_4_55_1","unstructured":"Pages. [cited 2023 May 26]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05087589"},{"key":"e_1_3_4_56_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04822584"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-020-01322-w"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.161"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21750"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa894"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00152-1"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead215"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.881705"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.635663"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030423"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102796"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216900"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05973-4"},{"key":"e_1_3_4_70_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03725202"},{"key":"e_1_3_4_71_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04161898"},{"key":"e_1_3_4_72_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04299971"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220832"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207578"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13525"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.15459"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.5004a"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00361-1"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.03.027"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223562"},{"key":"e_1_3_4_81_1","first-page":"74","article-title":"Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica (EAST PMR): a prospective study [abstract]","volume":"20","author":"Ma X","year":"2022","unstructured":"Ma X, Yang F, Lin J, et al. Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica (EAST PMR): a prospective study [abstract]. Arthritis Rheumatol. 2022;20:74.","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05819-z"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkac034"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103334"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-021-00182-1"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102831"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/hxin6o"},{"key":"e_1_3_4_88_1","unstructured":"Pages. [cited 2023 May 25]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04972760"},{"key":"e_1_3_4_89_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04208464"},{"key":"e_1_3_4_90_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05437263"},{"key":"e_1_3_4_91_1","unstructured":"Pages. [cited 2023 May 25]. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04966884"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41602"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab116"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1900045"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab421"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2089323"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39818"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23361-z"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S397639"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31363-1"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31574-5"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02607-1"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02546-6"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00342-2"},{"key":"e_1_3_4_105_1","volume-title":"AbbVie advances upadacitinib (RINVOQ\u00ae) to phase 3 clinical trials in systemic lupus erythematosus","author":"Pawliw K","year":"2023","unstructured":"Pawliw K. AbbVie advances upadacitinib (RINVOQ\u00ae) to phase 3 clinical trials in systemic lupus erythematosus. Chicago, IL: AbbVie; 2023."},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42391"},{"key":"e_1_3_4_107_1","unstructured":"Pages. Accessed at ClinicalTrials.gov at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05617677"},{"key":"e_1_3_4_108_1","unstructured":"Pages. Accessed at ClinicalTrials.gov at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05620407"},{"key":"e_1_3_4_109_1","unstructured":"Pages. Accessed at ClinicalTrials.gov at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04857034 cited 2023 May 27"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105592"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221733"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1117"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2023.2249237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:55:38Z","timestamp":1698152138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2023.2249237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":110,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/1744666X.2023.2249237"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2023.2249237","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}